Novartis’ Alcon Partners With Eye Device Startup PowerVision

Alcon, the eye care business of Novartis, has announced an alliance with privately-held medical device startup PowerVision, which has developed a fluid-based lens implant for cataract patients who also have presbyopia, the age-related visual condition that makes it difficult to focus on close objects. The deal also provides Alcon the option to acquire PowerVision.